Palvella Therapeutics receives Yale-licensed patent for QTORIN pitavastatin

Go back to Palvella Therapeutics receives Yale-licensed patent for QTORIN pitavastatin
(NASDAQ: PVLA) Delayed: 113.10 --0 (-0%)
Previous Close $113.10    52 Week High
Open $113.10    52 Week Low
Day High $113.10    P/E N/A 
Day Low $113.10    EPS
Volume 70